#her2low Tweet Chat
ASCP is hosting a CME/CMLE-accredited Twitter chat to allow you to engage with experts and your peers on discussions around HER2-low breast cancer, HER2 testing guidelines, and the implications for the pathology team as HER2-low therapies emerge.
Start: Thu 10th Mar 2022 – 8 pm Eastern#her2low is a healthcare tweet chat hashtag submitted by @DrJosephKim
